BioNTech SE

Bristol Myers Squibb is following Merck & Co. and Pfizer by buying into the bispecific PD-L1xVEGF-targeting mechanism for cancer, announcing on June 2 that it will pay $1.5bn up front to BioNTech

Confused and alarmed stakeholders worry that Health and Human Services Secretary Robert F. Kennedy Jr. usurped a role long played by the US Centers for Disease Control and Prevention and its external

The US Food and Drug Administration’s vaccine advisors split on whether COVID-19 vaccine manufacturers should update shots with a new strain for the 2025-2026 vaccine season, as uncertainty about the

Market analysts have deemed the US Food and Drug Administration’s COVID-19 vaccine policy unveiled 20 May as far from a worst-case scenario for vaccine-focused firms – for example, approved vaccines w